Cargando…

Nucleosides for the treatment of respiratory RNA virus infections

Influenza virus, respiratory syncytial virus, human metapneumovirus, parainfluenza virus, coronaviruses, and rhinoviruses are among the most common viruses causing mild seasonal colds. These RNA viruses can also cause lower respiratory tract infections leading to bronchiolitis and pneumonia. Young c...

Descripción completa

Detalles Bibliográficos
Autores principales: Jordan, Paul C, Stevens, Sarah K, Deval, Jerome
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890544/
https://www.ncbi.nlm.nih.gov/pubmed/29562753
http://dx.doi.org/10.1177/2040206618764483
_version_ 1783312881277730816
author Jordan, Paul C
Stevens, Sarah K
Deval, Jerome
author_facet Jordan, Paul C
Stevens, Sarah K
Deval, Jerome
author_sort Jordan, Paul C
collection PubMed
description Influenza virus, respiratory syncytial virus, human metapneumovirus, parainfluenza virus, coronaviruses, and rhinoviruses are among the most common viruses causing mild seasonal colds. These RNA viruses can also cause lower respiratory tract infections leading to bronchiolitis and pneumonia. Young children, the elderly, and patients with compromised cardiac, pulmonary, or immune systems are at greatest risk for serious disease associated with these RNA virus respiratory infections. In addition, swine and avian influenza viruses, together with severe acute respiratory syndrome-associated and Middle Eastern respiratory syndrome coronaviruses, represent significant pandemic threats to the general population. In this review, we describe the current medical need resulting from respiratory infections caused by RNA viruses, which justifies drug discovery efforts to identify new therapeutic agents. The RNA polymerase of respiratory viruses represents an attractive target for nucleoside and nucleotide analogs acting as inhibitors of RNA chain synthesis. Here, we present the molecular, biochemical, and structural fundamentals of the polymerase of the four major families of RNA respiratory viruses: Orthomyxoviridae, Pneumoviridae/Paramyxoviridae, Coronaviridae, and Picornaviridae. We summarize past and current efforts to develop nucleoside and nucleotide analogs as antiviral agents against respiratory virus infections. This includes molecules with very broad antiviral spectrum such as ribavirin and T-705 (favipiravir), and others targeting more specifically one or a few virus families. Recent advances in our understanding of the structure(s) and function(s) of respiratory virus polymerases will likely support the discovery and development of novel nucleoside analogs.
format Online
Article
Text
id pubmed-5890544
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-58905442018-04-17 Nucleosides for the treatment of respiratory RNA virus infections Jordan, Paul C Stevens, Sarah K Deval, Jerome Antivir Chem Chemother Original Article Influenza virus, respiratory syncytial virus, human metapneumovirus, parainfluenza virus, coronaviruses, and rhinoviruses are among the most common viruses causing mild seasonal colds. These RNA viruses can also cause lower respiratory tract infections leading to bronchiolitis and pneumonia. Young children, the elderly, and patients with compromised cardiac, pulmonary, or immune systems are at greatest risk for serious disease associated with these RNA virus respiratory infections. In addition, swine and avian influenza viruses, together with severe acute respiratory syndrome-associated and Middle Eastern respiratory syndrome coronaviruses, represent significant pandemic threats to the general population. In this review, we describe the current medical need resulting from respiratory infections caused by RNA viruses, which justifies drug discovery efforts to identify new therapeutic agents. The RNA polymerase of respiratory viruses represents an attractive target for nucleoside and nucleotide analogs acting as inhibitors of RNA chain synthesis. Here, we present the molecular, biochemical, and structural fundamentals of the polymerase of the four major families of RNA respiratory viruses: Orthomyxoviridae, Pneumoviridae/Paramyxoviridae, Coronaviridae, and Picornaviridae. We summarize past and current efforts to develop nucleoside and nucleotide analogs as antiviral agents against respiratory virus infections. This includes molecules with very broad antiviral spectrum such as ribavirin and T-705 (favipiravir), and others targeting more specifically one or a few virus families. Recent advances in our understanding of the structure(s) and function(s) of respiratory virus polymerases will likely support the discovery and development of novel nucleoside analogs. SAGE Publications 2018-03-21 /pmc/articles/PMC5890544/ /pubmed/29562753 http://dx.doi.org/10.1177/2040206618764483 Text en © The Author(s) 2018 http://creativecommons.org/licenses/by-nc/4.0/ Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Article
Jordan, Paul C
Stevens, Sarah K
Deval, Jerome
Nucleosides for the treatment of respiratory RNA virus infections
title Nucleosides for the treatment of respiratory RNA virus infections
title_full Nucleosides for the treatment of respiratory RNA virus infections
title_fullStr Nucleosides for the treatment of respiratory RNA virus infections
title_full_unstemmed Nucleosides for the treatment of respiratory RNA virus infections
title_short Nucleosides for the treatment of respiratory RNA virus infections
title_sort nucleosides for the treatment of respiratory rna virus infections
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890544/
https://www.ncbi.nlm.nih.gov/pubmed/29562753
http://dx.doi.org/10.1177/2040206618764483
work_keys_str_mv AT jordanpaulc nucleosidesforthetreatmentofrespiratoryrnavirusinfections
AT stevenssarahk nucleosidesforthetreatmentofrespiratoryrnavirusinfections
AT devaljerome nucleosidesforthetreatmentofrespiratoryrnavirusinfections